Press release
Intravenous Immunoglobulin (IVIG) Market Size Soaring at 7.1% CAGR to reach $12,632 Million by 2022: Top Players Baxter international, Grifols, Octapharma AG, Kedrion Biopharma
Immunoglobulins (IGs), also known as antibodies, are glycoproteins produced by the blood plasma in response to foreign bodies or antigens. They are highly complex entities and are specific in their action. These IGs are obtained from blood through the process of fractionation and are purified for use in therapeutic and non-therapeutic areas. The global intravenous immunoglobulin (IGIV) market was valued at $7,861 million in 2015 and is projected to reach $12,632 million by 2022, registering a CAGR of 7.1% from 2016 to 2022.
Request a Sample Copy: https://www.bigmarketresearch.com/request-sample/2819888?utm_source=OPR&utm_medium=CC
Increase in prevalence of immunodeficiency and autoimmune diseases such as chronic inflammatory demyelinating polyneuropathy, hypogammaglobulinemia & others and rise in adoption of immunoglobulin treatments for the treatment of various autoimmune disorders majorly drive the growth of the IVIG market. Further, the increase in approval of IVIG drugs from the Food and Drug Administration (FDA), European Medicine Agency (EMA), and other government agencies is expected to accelerate the market growth of IVIG industry. However, stringent government regulations, inflated cost of therapy, and high risk of side effects associated with the use of immunoglobulin intravenously are anticipated to hamper the market growth. On the contrary, significant investment in healthcare sector is expected to provide lucrative opportunities for the market growth in the near future.
The global IVIG market is characterized based on application, type, and region. Based on application, the market is segmented into hypogammaglobulinemia, CIDP, immunodeficiency diseases, myasthenia gravis, multifocal motor neuropathy, idiopathic thrombocytopenic purpura (ITP), inflammatory myopathies, specific antibody deficiency, Guillain‐Barre syndrome, and others. Based on type, the market is classified into IgG, IgA, IgM, IgE, and IgD. By region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Read the Full Report Description with Table of Content: https://www.bigmarketresearch.com/intravenous-immunoglobulin-IVIG-market?utm_source=OPR&utm_medium=CC
Top companies have been profiled in this research report such as Baxter international Inc., CSL Ltd., Grifols, S.A., Octapharma AG, Kedrion Biopharma Inc., LFB group, Biotest AG, China Biologics Products, Inc., Shire Plc. (Baxalta) and Bayer AG.
Related Report:
Immunoglobulin Market by Application, Product and by Mode of Delivery: Global Opportunity Analysis and Industry Forecast, 2018 - 2025
The global immunoglobulin was valued at $9,851 million in 2017, and is projected to reach $17,501 million by 2025, registering a CAGR of 7.5% from 2018 to 2025.
Immunoglobulins (IGs) or antibodies are glycoproteins produced in the blood plasma in response to the antigens, which are foreign to the host system. They are highly complex entities and are specific in their action. They are obtained from blood through the process of fractionation and are purified for therapeutic and non-therapeutic applications. In therapeutics, they are administered intravenously for the treatment of various deficiencies.
Increase in prevalence of immunodeficiency and autoimmune diseases such as chronic inflammatory demyelinating polyneuropathy, hypogammaglobulinemia & others and rise in adoption of immunoglobulin treatments for the treatment of various autoimmune disorders majorly drive the growth of the immunoglobulin market.
Read More: https://www.bigmarketresearch.com/immunoglobulin-market?utm_source=OPR&utm_medium=CC
About Us:
Big Market Research has a range of research reports from various publishers across the world. Our database of reports of various market categories and sub-categories would help to find the exact report you may be looking for.
We are instrumental in providing quantitative and qualitative insights on your area of interest by bringing reports from various publishers at one place to save your time and money. A lot of organizations across the world are gaining profits and great benefits from information gained through reports sourced by us.
Contact us:
5933 NE Win Sivers Drive, #205, Portland,
OR 97220 United States
Direct: +1-971-202-1575
Toll Free: +1-800-910-6452
E-mail help@bigmarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Intravenous Immunoglobulin (IVIG) Market Size Soaring at 7.1% CAGR to reach $12,632 Million by 2022: Top Players Baxter international, Grifols, Octapharma AG, Kedrion Biopharma here
News-ID: 1407306 • Views: …
More Releases from Big Market Research
Micro Drone Market to Witness a Pronounce Growth during 2025
The Global Micro Drone Market report is one of the most comprehensive and important data about business strategies, qualitative and quantitative analysis of the Global Market. Micro Drone Market research report offers extensive research and analysis of key aspects of the global Micro Drone market.
The report provides brief summary and detailed insights into the market by collecting data from the industry experts and several prevalent in the market. Besides…
Lancing Device Market VALUATION TO BOOM THROUGH 2025
The Global Lancing Device Market report is one of the most comprehensive and important data about business strategies, qualitative and quantitative analysis of the Global Market. Lancing Device Market research report offers extensive research and analysis of key aspects of the global Lancing Device market.
The report provides brief summary and detailed insights into the market by collecting data from the industry experts and several prevalent in the market. Besides…
VET Diagnostic Market Insights, Technology Advancements and Forecast 2025
The Global VET Diagnostic Market report is one of the most comprehensive and important data about business strategies, qualitative and quantitative analysis of the Global Market. VET Diagnostic Market research report offers extensive research and analysis of key aspects of the global VET Diagnostic market.
The report provides brief summary and detailed insights into the market by collecting data from the industry experts and several prevalent in the market. Besides…
Application Modernization Tools Market to Witness a Pronounce Growth during 2025
The Global Application Modernization Tools Market report is one of the most comprehensive and important data about business strategies, qualitative and quantitative analysis of the Global Market. Application Modernization Tools Market research report offers extensive research and analysis of key aspects of the global Application Modernization Tools market.
The report provides brief summary and detailed insights into the market by collecting data from the industry experts and several prevalent in…
More Releases for IVIG
IVIg Powder Market 2022-2028 Global Key Manufacturers' Analysis Review
The "Global IVIg Powder Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the IVIg Powder market with detailed market segmentation by drug class and distribution channel. The report provides key statistics on the market status of the leading IVIg Powder market players and offers key trends…
Intravenous Immunoglobulin (IVIG) Market Size, Share | Industry Report 2026
The global Intravenous Immunoglobulin Market was valued at $13.7Billion in 2018 and is forecast to grow at a modestxx.3 % CAGR between 2018 and 2026, culminating in 2026 global sales of $16.7Billion.
Intravenous Immunoglobulin (IVIG) is a solution of highly purified immunoglobulin G, derived from large human plasma that contains antibodies against a broad spectrum of bacterial and viral agents. Intravenous immunoglobulin of properties isa composition that addition of albumin,…
Intravenous Immunoglobulin (IVIG) Market: Rising Prevalence of Neurological Dise …
This report on the global intravenous immunoglobulin (IVIG) market analyzes the current and future prospects of the market. The report comprises an elaborate executive summary, including a market snapshot that provides overall information of various segments and sub-segments. The research is a combination of primary and secondary research. Primary research formed the bulk of our research efforts along with information collected from telephonic interviews and interactions via e-mails.
Secondary research…
Intravenous Immunoglobulin (IVIG) Market: Rising Production of IVIG Products are …
The global market for intravenous immunoglobulin (IVIG) products and therapies is heading in a positive direction due to several innovative techniques and advantages it offers to clinicians worldwide. The market is expected to expand at a healthy pace in the near future. Factors that will support market’s growth include technological improvements in the methods used for production and purification of IVIG products and an improving health care infrastructure across the…
Global Intravenous Immunoglobulin (IVIg) Market
The Intravenous Immunoglobulin Market report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
The term “immunoglobulin” refers to the breakdown of blood plasma that contains antibody. IVIg is a blood product which is administered intravenously. It contains polyvalent IgG antibodies which are extracted from…
Global Intravenous Immunoglobulin (IVIG) Market: Rising Patient Pool of Neurolog …
The global intravenous immunoglobulin (IVIG) market is largely consolidated, with top four players: Grifols S.A., CSL Behring LLC, Baxalta Incorporated, and Octapharma AG, accounting for over 70% of the overall market in 2015. Grifols S.A. accounted for the dominant share of 23.0%, chiefly on account of the company’s strong geographic penetration.
Oligopoly in the market has led to intense competition among top players and has compelled companies to take course of…
